7 Results for "

H838

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "H838" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-149508
CAS No.: 6325-13-9
Purity:  99.19%
Research Areas:  

Cancer

Nrf2-IN-3 (Compound R16) is a small-molecule NRF2 inhibitor and increases reactive oxygen species (ROS) production. Nrf2-IN-3 selectively binds KEAP1 mutants and restores their NRF2-inhibitory function by repairing the disrupted KEAP1/NRF2 interactions, leading to proteasome-dependent NRF2 degradation in cells. Nrf2-IN-3 sensitizes KEAP1-mutated tumor cells to Cisplatin (HY-17394), Gefitinib (HY-50895), and KEAP1 G333C-mutated xenograft to Cisplatin .
loading...
    loading...
Cat. No.: HY-163428
CAS No.: 2414056-31-6
Synonyms: ZN-A-1041
Target:  

EGFR

Research Areas:  

Inflammation/Immunology Cancer

ZN-A-1041 inhibits HER2 in BT474 cell and wt-EGFR in H838 cells, with IC50s of 9.5 nM and 12 μM respectively. ZN-A-1041 can be used for research of cancer and inflammation .
loading...
    loading...
Cat. No.: HY-156568
CAS No.: 3033109-92-8
Purity:  99.91%
Target:  

PROTACs SWI/SNF Complex

Research Areas:  

Cancer

SMD-3040 is a potent and selective SMARCA2 PROTAC degrader (DC50: 12 nM; Dmax: 91%). SMD-3040 can inhibit tumor cell proliferation and exhibits antitumor activity. SMD-3040 can be used in the study of tumors such as melanoma .
loading...
    loading...
Cat. No.: HY-168847
CAS No.: 2923669-20-7
Target:  

Ras

Research Areas:  

Cancer

INCB159020 is an orally active KRAS G12D inhibitor with equivalent binding potency for the active GTP-bound and inactive GDP-bound forms of KRAS G12D. INCB159020 can be used in the research of KRAS-driven cancers .
loading...
    loading...
Cat. No.: HY-156568B
Purity:  99.78%
Target:  

PROTACs SWI/SNF Complex

Research Areas:  

Cancer

SMD-3040 formate is a potent and selective SMARCA2 PROTAC degrader (DC50: 12 nM; Dmax: 91%). SMD-3040 formate can inhibit tumor cell proliferation and exhibits antitumor activity. SMD-3040 formate can be used in the study of tumors such as melanoma .
loading...
    loading...
Cat. No.: HY-156568A
Purity:  99.90%
Target:  

PROTACs SWI/SNF Complex

Research Areas:  

Cancer

SMD-3040 TFA is a potent and selective SMARCA2 PROTAC degrader (DC50: 12 nM; Dmax: 91%). SMD-3040 TFA can inhibit tumor cell proliferation and exhibits antitumor activity. SMD-3040 TFA can be used in the study of tumors such as melanoma . (SMARCA2/4-ligand (HY-171765); HY-112078 VHL ligand (HY-112078))
loading...
    loading...
Cat. No.: HY-184673
CAS No.: 3086248-19-0
Target:  

PROTACs SWI/SNF Complex

Research Areas:  

Cancer

SMD-6346 is an orally active SMARCA2 PROTAC degrader with a DC50 of 3.3 nM. SMD-6346 induces SMARCA2 degradation and exhibits extremely low activity against SMARCA4. SMD-6346 inhibits the growth of SMARCA4-deficient cancer cells and suppresses tumor growth in mouse xenograft models. SMD-6346 can be used for the research of non-small cell lung cancer .
loading...
    loading...